Oncolytics Biotech Inc.
ONCY
$0.81
-$0.03-3.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.73M | 6.56M | 4.59M | 2.09M | 2.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.28M | 9.36M | 10.05M | 4.12M | 5.02M |
| Operating Income | -9.28M | -9.36M | -10.05M | -4.12M | -5.02M |
| Income Before Tax | -9.24M | -8.68M | -10.64M | -4.39M | -4.71M |
| Income Tax Expenses | -- | 200.80K | -183.00K | 61.40K | -- |
| Earnings from Continuing Operations | -9.24M | -8.88M | -10.46M | -4.46M | -4.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.24M | -8.88M | -10.46M | -4.46M | -4.71M |
| EBIT | -9.28M | -9.36M | -10.05M | -4.12M | -5.02M |
| EBITDA | -9.27M | -9.35M | -10.03M | -4.11M | -5.00M |
| EPS Basic | -0.08 | -0.08 | -0.10 | -0.05 | -0.06 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.07 | -0.03 | -0.03 |
| EPS Diluted | -0.08 | -0.08 | -0.10 | -0.05 | -0.06 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.07 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 112.29M | 106.30M | 101.32M | 91.00M | 84.63M |
| Average Diluted Shares Outstanding | 112.29M | 106.30M | 101.32M | 91.00M | 84.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |